Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer

Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer

FromKeeping Current CME


Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer

FromKeeping Current CME

ratings:
Length:
32 minutes
Released:
Mar 28, 2024
Format:
Podcast episode

Description

How do you define high-risk for recurrence in breast cancer? Credit available for this activity expires: [03/27/25] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000352?ecd=bdc_podcast_libsyn_mscpedu  
Released:
Mar 28, 2024
Format:
Podcast episode

Titles in the series (100)

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.